New treatment possibility for some cancer patients

Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.

New treatment possibility for ER+ breast cancer is headed toward clinical trials, News & Stories

Chemo helps breast cancer cells get their 'foot in the door' to the lungs

New treatments possible for a rare childhood cancer

New breast cancer treatment could help thousands of women - as it 'slashes risk of disease returning by a quarter

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Clinical update, Cancer Nursing Practice

How Immunotherapy Works To Treat Cancer

New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment - Physician Resources

PSMA-therapy with Actinium-225

Lynne Pearce, Page 12